Home > News > Nanogen Reports 2004 First Quarter Results
May 3rd, 2004
Nanogen Reports 2004 First Quarter Results
Nanogen, Inc. (Nasdaq: NGEN), developer of molecular and point-of-care diagnostic products, today announced its financial results for the first quarter ended March 31, 2004. Total revenues for the first quarter of 2004 were $2.2 million compared to $1.2 million for the same period in 2003 and $2.1 million in the fourth quarter of 2003. Product revenues for the first quarter were $1.1 million versus $228,000 for the same period in 2003 and were approximately equal to the prior quarter.
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their March 17th, 2014
Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014
Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014